Oksen, D.; Aslan, M.; Serin, E.; Gecit, M.H.; Yavuz, Y.E.; Zerdali, E.Y.; Oktay, V.
Evaluation of Subclinical Left Ventricular Dysfunction in HIV Patients Receiving Abacavir, Dolutegravir, and Lamivudine Therapy with Novel Tissue Doppler Imaging Techniques. J. Clin. Med. 2025, 14, 1534.
https://doi.org/10.3390/jcm14051534
AMA Style
Oksen D, Aslan M, Serin E, Gecit MH, Yavuz YE, Zerdali EY, Oktay V.
Evaluation of Subclinical Left Ventricular Dysfunction in HIV Patients Receiving Abacavir, Dolutegravir, and Lamivudine Therapy with Novel Tissue Doppler Imaging Techniques. Journal of Clinical Medicine. 2025; 14(5):1534.
https://doi.org/10.3390/jcm14051534
Chicago/Turabian Style
Oksen, Dogac, Muzaffer Aslan, Ebru Serin, Muhammed Heja Gecit, Yunus Emre Yavuz, Esra Yerlikaya Zerdali, and Veysel Oktay.
2025. "Evaluation of Subclinical Left Ventricular Dysfunction in HIV Patients Receiving Abacavir, Dolutegravir, and Lamivudine Therapy with Novel Tissue Doppler Imaging Techniques" Journal of Clinical Medicine 14, no. 5: 1534.
https://doi.org/10.3390/jcm14051534
APA Style
Oksen, D., Aslan, M., Serin, E., Gecit, M. H., Yavuz, Y. E., Zerdali, E. Y., & Oktay, V.
(2025). Evaluation of Subclinical Left Ventricular Dysfunction in HIV Patients Receiving Abacavir, Dolutegravir, and Lamivudine Therapy with Novel Tissue Doppler Imaging Techniques. Journal of Clinical Medicine, 14(5), 1534.
https://doi.org/10.3390/jcm14051534
